These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 32278827

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome.
    Abu Lila AS, Ichihara M, Shimizu T, Ishida T, Kiwada H.
    Biol Pharm Bull; 2013; 36(11):1842-8. PubMed ID: 24189428
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM.
    Wang F, Ye X, Wu Y, Wang H, Sheng C, Peng D, Chen W.
    J Pharm Sci; 2019 Jan; 108(1):641-651. PubMed ID: 30595169
    [Abstract] [Full Text] [Related]

  • 5. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
    Shimizu T, Ishida T, Kiwada H.
    Immunobiology; 2013 May; 218(5):725-32. PubMed ID: 22995937
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism.
    Elsadek NE, Emam SE, Abu Lila AS, Shimizu T, Ando H, Ishima Y, Ishida T.
    Biol Pharm Bull; 2020 May; 43(9):1393-1397. PubMed ID: 32879214
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
    Shimizu T, Abu Lila AS, Fujita R, Awata M, Kawanishi M, Hashimoto Y, Okuhira K, Ishima Y, Ishida T.
    Eur J Pharm Biopharm; 2018 Jun; 127():142-149. PubMed ID: 29462689
    [Abstract] [Full Text] [Related]

  • 11. Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice.
    Emam SE, Elsadek NE, Abu Lila AS, Takata H, Kawaguchi Y, Shimizu T, Ando H, Ishima Y, Ishida T.
    J Control Release; 2021 Jun 10; 334():327-334. PubMed ID: 33957196
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.
    Abu Lila AS, Kiwada H, Ishida T.
    J Control Release; 2013 Nov 28; 172(1):38-47. PubMed ID: 23933235
    [Abstract] [Full Text] [Related]

  • 16. A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes.
    El Sayed MM, Shimizu T, Abu Lila AS, Elsadek NE, Emam SE, Alaaeldin E, Kamal A, Sarhan HA, Ando H, Ishima Y, Ishida T.
    Int J Pharm; 2022 Mar 05; 615():121539. PubMed ID: 35124114
    [Abstract] [Full Text] [Related]

  • 17. Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance.
    Kaminskas LM, McLeod VM, Porter CJ, Boyd BJ.
    J Pharm Sci; 2011 Nov 05; 100(11):5069-77. PubMed ID: 21721002
    [Abstract] [Full Text] [Related]

  • 18. [Elucidation of accelerated blood clearance phenomenon caused by repeat injection of PEGylated nanocarriers].
    Koide H, Asai T, Hatanaka K, Shimizu K, Yokoyama M, Ishida T, Kiwada H, Oku N.
    Yakugaku Zasshi; 2009 Dec 05; 129(12):1445-51. PubMed ID: 19952519
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon.
    Shiraishi K, Hamano M, Ma H, Kawano K, Maitani Y, Aoshi T, Ishii KJ, Yokoyama M.
    J Control Release; 2013 Feb 10; 165(3):183-90. PubMed ID: 23220106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.